In line with these observations, both exogenous BDNF administration and BDNF gene transfer in a mouse model of obesity and type 2 diabetes mellitus restore normal food intake, inducing weight loss and decreasing insulin resistance [17,18], which supports the concept that BDNF deficit in the brain induces a metabotropic impairment leading to obesity [19,20]. The gene discussed is BDNF; the disease is obesity disorder.